Circulating Biomarkers and Extracellular Vesicles Europe 2024 - Two Day On Site Conference Takes Place in Rotterdam, Netherlands on June 24-25th 2024
June 06, 2024 07:42 ET
|
Research and Markets
Dublin, June 06, 2024 (GLOBE NEWSWIRE) -- The "Circulating Biomarkers and Extracellular Vesicles Europe 2024" conference has been added to ResearchAndMarkets.com's offering.The Circulating...
China Biopsy Market Report 2024-2032: Chinese Government Releases 8 Year Plan for Cancer Prevention and Treatment, to Achieve 46.6% Five Year Survival Rate among Cancer Patients by 2030
June 04, 2024 09:18 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "China Biopsy Market Report by Products, Imaging Technology, End-User, and Company Analysis 2024-2032" report has been added to ...
Global Liquid Biopsy Market Report 2024: A Rapidly Growing Sector with Numerous Companies Focusing on Scientific Advancement, Market Set to Reach US$ 13.72 Billion by 2031
June 04, 2024 05:39 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market, Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031" report has been added to ...
U.S. Liquid Biopsy Market Initiatives, Funding, Major Deals, Company Profiles and Recent Developments - Forecast to 2031
June 04, 2024 04:08 ET
|
Research and Markets
Dublin, June 04, 2024 (GLOBE NEWSWIRE) -- The "United States Liquid Biopsy Market (by Circulating Biomarker, Product, Application, Cancer Types, Non-Cancer Application, End User, Clinical...
Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Blood Test
June 02, 2024 10:00 ET
|
Precede Biosciences, Inc.
HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancersER status was accurately assessed and the level of ER pathway activation quantified in 87...
Liquid Biopsy Market is Expected to Reach $11.3 billion | MarketsandMarkets™
May 27, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 27, 2024 (GLOBE NEWSWIRE) -- Liquid Biopsy market in terms of revenue was estimated to be worth $6.4 billion in 2024 and is poised to reach $11.3 billion by 2029, growing at a CAGR of...
Global Liquid Biopsy Market Report 2024: Early Cancer Screening Segment Accounted for the Highest Growth Rate in the Liquid Biopsy market, by Clinical Application
May 27, 2024 03:10 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (CTC, ctDNA, cfDNA), Technology (NGS, PCR), Application...
Global EV-Based Liquid Biopsy Industry Research 2024: Market Size, Share, Trends, Opportunities, and Forecasts, 2019-2029F
May 08, 2024 09:12 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "EV-Based Liquid Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Circulating Tumor Cell (CTC) Market Forecast to Reach $26.1 Billion by 2032: Key Global and Regional Insights by Technology, Application, Product, Specimen, and End User
May 08, 2024 05:48 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2024-2032" report has been added to ...
Global Exosome Research Market Outlook 2024-2028: Escalating Interest in Exosome-based Therapeutics
May 07, 2024 12:54 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer,...